GlucoTrack shares jumped 15.98% after-hours as investors reacted to Lokahi Therapeutics merger news and restructuring plans.

Glucotrack Inc. shares jumped 69.27% after hours as investors reacted to the company's newly allowed U.S. patent for its glucose monitoring.

GlucoTrack shares jumped 15.98% after-hours as investors reacted to Lokahi Therapeutics merger news and restructuring plans.